Patents by Inventor Tomoyuki Mashiko
Tomoyuki Mashiko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11569450Abstract: The present invention provides a photoelectric conversion element having excellent heat resistance. In addition, the present invention provides an optical sensor and an imaging element including the photoelectric conversion element. In addition, the present invention provides a compound applied to the photoelectric conversion element. The photoelectric conversion element according to the embodiment of the present invention including a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1) or (2).Type: GrantFiled: May 7, 2020Date of Patent: January 31, 2023Assignee: FUJIFILM CorporationInventors: Tomoaki Yoshioka, Eiji Fukuzaki, Tomoyuki Mashiko
-
Patent number: 11171165Abstract: The present invention provides a photoelectric conversion element including a photoelectric conversion film having a narrow half-width of absorption peak and an excellent photoelectric conversion efficiency, and an imaging element, an optical sensor, and a compound. The photoelectric conversion element according to the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1).Type: GrantFiled: September 8, 2020Date of Patent: November 9, 2021Assignee: FUJIFILM CorporationInventors: Eiji Fukuzaki, Tomoyuki Mashiko, Tomoaki Yoshioka, Koichi Iwasaki
-
Patent number: 11161830Abstract: An object of the present invention is to provide a compound or a salt thereof having anti-HBV activity, a pharmaceutical composition, an anti-hepatitis B virus agent, a production inhibitor of DNA of a hepatitis B virus, and a production or secretion inhibitor of a hepatitis B surface antigen. According to the present invention, provided are a compound represented by General Formula [1] or a salt thereof: (in the formula, R1 represents a benzothiazolyl group which may be substituted (in which a carbon atom constituting the 6-membered ring of the benzothiazolyl group of R1 is bonded to the nitrogen atom of the pyridone ring); R2 represents a C2-6 alkenyl group which may be substituted, or the like; and R3 represents a hydrogen atom or the like).Type: GrantFiled: September 26, 2019Date of Patent: November 2, 2021Assignee: FUJIFILM CorporationInventors: Megumi Ookubo, Shinichiro Sekine, Tomoyuki Mashiko, Hyoei Kawai, Hirofumi Fukunaga
-
Publication number: 20210135128Abstract: The present invention is to provide a photoelectric conversion element having excellent heat resistance. In addition, an imaging element and an optical sensor which include the photoelectric conversion element are provided. Furthermore, a compound applied to the photoelectric conversion element is provided. A photoelectric conversion element according to the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1). In Formula (1), Y1 represents a group represented by Formula (1-1) or a group represented by Formula (1-2).Type: ApplicationFiled: January 11, 2021Publication date: May 6, 2021Applicant: FUJIFILM CorporationInventors: Tomoaki YOSHIOKA, Tomoyuki MASHIKO, Koichi IWASAKI
-
Publication number: 20210135121Abstract: A first object of the present invention is to provide a photoelectric conversion element which includes a photoelectric conversion film having a narrow half-width of an absorption peak and has excellent heat resistance. Moreover, a second object of the present invention is to provide an imaging element and an optical sensor. Furthermore, a third object of the present invention is to provide a novel compound. A photoelectric conversion element according to the embodiment of the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film in this order, in which the photoelectric conversion film contains a compound represented by Formula (1).Type: ApplicationFiled: November 25, 2020Publication date: May 6, 2021Applicant: FUJIFILM CorporationInventors: Tomoyuki MASHIKO, Tomoaki YOSHIOKA, Eiji FUKUZAKI
-
Publication number: 20200411569Abstract: The present invention provides a photoelectric conversion element including a photoelectric conversion film having a narrow half-width of absorption peak and an excellent photoelectric conversion efficiency, and an imaging element, an optical sensor, and a compound. The photoelectric conversion element according to the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1).Type: ApplicationFiled: September 8, 2020Publication date: December 31, 2020Applicant: FUJIFILM CorporationInventors: Eiji FUKUZAKI, Tomoyuki MASHIKO, Tomoaki YOSHIOKA, Koichi IWASAKI
-
Publication number: 20200403163Abstract: The present invention provides a photoelectric conversion element having a photoelectric conversion film having a narrow half-width of absorption peak, an imaging element, an optical sensor, and a compound. The photoelectric conversion element according to the embodiment of the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1).Type: ApplicationFiled: September 2, 2020Publication date: December 24, 2020Applicant: FUJIFILM CorporationInventors: Tomoaki YOSHIOKA, Eiji FUKUZAKI, Tomoyuki MASHIKO
-
Publication number: 20200266359Abstract: The present invention provides a photoelectric conversion element having excellent heat resistance. In addition, the present invention provides an optical sensor and an imaging element including the photoelectric conversion element. In addition, the present invention provides a compound applied to the photoelectric conversion element. The photoelectric conversion element according to the embodiment of the present invention including a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1) or (2).Type: ApplicationFiled: May 7, 2020Publication date: August 20, 2020Applicant: FUJIFILM CorporationInventors: Tomoaki YOSHIOKA, Eiji FUKUZAKI, Tomoyuki MASHIKO
-
Publication number: 20200017459Abstract: An object of the present invention is to provide a compound or a salt thereof having anti-HBV activity, a pharmaceutical composition, an anti-hepatitis B virus agent, a production inhibitor of DNA of a hepatitis B virus, and a production or secretion inhibitor of a hepatitis B surface antigen. According to the present invention, provided are a compound represented by General Formula [1] or a salt thereof: (in the formula, R1 represents a benzothiazolyl group which may be substituted (in which a carbon atom constituting the 6-membered ring of the benzothiazolyl group of R1 is bonded to the nitrogen atom of the pyridone ring); R2 represents a C2-6 alkenyl group which may be substituted, or the like; and R3 represents a hydrogen atom or the like).Type: ApplicationFiled: September 26, 2019Publication date: January 16, 2020Applicant: FUJIFILM CorporationInventors: Megumi Ookubo, Shinichiro Sekine, Tomoyuki Mashiko, Hyoei Kawai, Hirofumi Fukunaga
-
Patent number: 9783536Abstract: A compound represented by Formula [1](in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.Type: GrantFiled: July 9, 2015Date of Patent: October 10, 2017Assignee: FUJIFILM CorporationInventors: Hidetomo Furuyama, Hideki Kurihara, Takahiro Terao, Daisuke Nakagawa, Shintaro Tanabe, Takayuki Kato, Masahiko Yamamoto, Shinichiro Sekine, Tomoyuki Mashiko, Shinsuke Inuki, Satoshi Ueda
-
Publication number: 20150322063Abstract: A compound represented by Formula [1] (in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.Type: ApplicationFiled: July 9, 2015Publication date: November 12, 2015Applicant: FUJIFILM CorporationInventors: Hidetomo FURUYAMA, Hideki KURIHARA, Takahiro TERAO, Daisuke NAKAGAWA, Shintaro TANABE, Takayuki KATO, Masahiko YAMAMOTO, Shinichiro SEKINE, Tomoyuki MASHIKO, Shinsuke INUKI, Satoshi UEDA
-
Patent number: 9051310Abstract: The object of the present invention is to provide a compound and a pharmaceutical composition having excellent Syk inhibitory activity. According to the present invention, a nicotinamide derivative represented by the following formula (I) or a salt thereof is provided, wherein R1 is a substituent represented by the following formula (II-1), (III-1), or (IV-1) (wherein R3, R4, R5, n, and X1 have the same definitions as those described in the specification), and R2 is a pyridyl, indazolyl, phenyl, pyrazolopyridyl, benzisoxazolyl, pyrimidinyl, or quinolyl group, each of which optionally has at least one substituent.Type: GrantFiled: June 27, 2014Date of Patent: June 9, 2015Assignee: FUJIFILM CorporationInventors: Hideyasu Fujiwara, Shinsuke Mizumoto, Yohei Kubo, Hiyoku Nakata, Shinji Hagiwara, Yasutaka Baba, Takashi Tamura, Hidenobu Kuniyoshi, Tomoyuki Mashiko, Mari Yamamoto
-
Publication number: 20140309225Abstract: The object of the present invention is to provide a compound and a pharmaceutical composition having excellent Syk inhibitory activity. According to the present invention, a nicotinamide derivative represented by the following formula (I) or a salt thereof is provided, wherein R1 is a substituent represented by the following formula (II-1), (III-1), or (IV-1) (wherein R3, R4, R5, n, and X1 have the same definitions as those described in the specification), and R2 is a pyridyl, indazolyl, phenyl, pyrazolopyridyl, benzisoxazolyl, pyrimidinyl, or quinolyl group, each of which optionally has at least one substituent.Type: ApplicationFiled: June 27, 2014Publication date: October 16, 2014Applicant: FUJIFILM CorporationInventors: Hideyasu FUJIWARA, Shinsuke MIZUMOTO, Yohei KUBO, Hiyoku NAKATA, Shinji HAGIWARA, Yasutaka BABA, Takashi TAMURA, Hidenobu KUNIYOSHI, Tomoyuki MASHIKO, Mari YAMAMOTO
-
Patent number: 4679992Abstract: A turbo-compound compressor system includes a booster compressor connected to the output shaft of a power recovery turbine which is disposed downstream of the outlet of an expansion turbine in a turbocharger for an internal combustion engine and drivable by the exhaust gas of the engine, and a rotary positive-displacement air compressor drivable by the engine also into which the air delivered by the booster compressor is supplied through an air supply conduit having a throttle valve. The turbo-compound compressor system further includes a bypass line provided therein with a closing valve and adapted to prevent surging caused in the booster compressor.Type: GrantFiled: October 1, 1984Date of Patent: July 14, 1987Assignee: Kabushiki Kaisha Komatsu SeisakushoInventors: Kinichiro Watanabe, Kunio Horiai, Tomoyuki Mashiko, Hitoshi Kato, Hiromasa Yamaguchi, Toshihiko Nishiyama